Ming Lu, based in Peking, Beijing, China, is currently a Chief Medical Officer at Tasly Pharmaceutica Group Co., Ltd., bringing experience from previous roles at Senior Vice President, CMO in Shanghai Henlius Biotech Inc., Ono Pharma USA, Tasly Biopharmaceuticals and Helsinn Therapeutics. Ming Lu holds a 1994 - 1997 Postdoc @ The Johns Hopkins University School of Medicine. With a robust skill set that includes Clinical Development, Clinical Trials, Pharmacovigilance, Clinical Research, Oncology and more, Ming Lu contributes valuable insights to the industry. Ming Lu has 3 emails on RocketReach.